Jose R. Gonzalez-Lorenzo
Vigo, GA, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.
Journal: Therapeutic advances in neurological disorders
Published: January 14, 2026
[Translated article] Alemtuzumab in relapsing-remitting multiple sclerosis in clinical practice: Annual NEDA-3 follow-up for up to 4 years.
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: May 01, 2025
Alemtuzumab in relapsing-remitting multiple sclerosis in clinical practice: Annual NEDA-3 follow-up for up to 4 years.
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
Published: May 01, 2025
Valuation of automatized ASPECTS as an artificial intelligence tool in daily clinical
Journal: Revista de neurologia
Published: December 20, 2021
Progression of a series of patients with relapsing-remitting multiple sclerosis treated for 7 years with natalizumab using the "no evidence of disease activity" parameter.
Journal: Neurologia
Published: June 07, 2017
Fingolimod: effectiveness and safety in routine clinical practice. An observational, retrospective, multi-centre study in Galicia
Journal: Revista de neurologia
Published: September 24, 2016
Assessment of the effectiveness and safety of Sativex® in compassionate use
Journal: Revista de neurologia
Published: February 25, 2015
Tropical spastic paraparesis: a report of a new case in Spain
Journal: Revista de neurologia
Published: June 11, 2014
Leber's optic neuropathy, ten years on: Harding's syndrome
Journal: Revista de neurologia
Published: March 11, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026